CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Simcere Zaiming signe un accord de licence exclusif avec Roche pour le développement mondial du SIM0660

PartnershipSIM0660Positive
AI Analysis

Summary

Simcere Zaiming signed an exclusive global licensing agreement with Roche for development and commercialization of SIM0660, a trispecific antibody candidate.

Outcome Details

Exclusive global licensing agreement signed for development and commercialization

Importance:7/10
Sentiment:
0.70
licensingpartnershipantibodytrispecificglobal development
Related Companies
$RHHBY

Read the original article

Published by PR Newswire Biotech on September 2, 2026 4:49 PM

Read Original